BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38658108)

  • 1. Malignant Hypertension:A Systemic Cardiovascular Disease: JACC Review Topic of the Week.
    Boulestreau R; Śpiewak M; Januszewicz A; Kreutz R; Guzik TJ; Januszewicz M; Muiesan ML; Persu A; Sarafidis P; Volpe M; Zaleska-Żmijewska A; van den Born BH; Messerli FH
    J Am Coll Cardiol; 2024 Apr; 83(17):1688-1701. PubMed ID: 38658108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant hypertension and hypertensive emergencies.
    Kitiyakara C; Guzman NJ
    J Am Soc Nephrol; 1998 Jan; 9(1):133-42. PubMed ID: 9440098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant hypertension: new aspects of an old clinical entity.
    Januszewicz A; Guzik T; Prejbisz A; Mikołajczyk T; Osmenda G; Januszewicz W
    Pol Arch Med Wewn; 2016; 126(1-2):86-93. PubMed ID: 26658350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency.
    Cremer A; Amraoui F; Lip GY; Morales E; Rubin S; Segura J; Van den Born BJ; Gosse P
    J Hum Hypertens; 2016 Aug; 30(8):463-6. PubMed ID: 26582411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypertensive urgencies and emergencies].
    Santamaría R; Gorostidi M
    Hipertens Riesgo Vasc; 2017; 34 Suppl 2():35-38. PubMed ID: 29908665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertensive emergency and urgence].
    Gegenhuber A; Lenz K
    Herz; 2003 Dec; 28(8):717-24. PubMed ID: 14689106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistant hypertension, secondary hypertension, and hypertensive crises: diagnostic evaluation and treatment.
    Acelajado MC; Calhoun DA
    Cardiol Clin; 2010 Nov; 28(4):639-54. PubMed ID: 20937447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypertensive urgency and emergency].
    Henny-Fullin K; Buess D; Handschin A; Leuppi J; Dieterle T
    Ther Umsch; 2015 Jun; 72(6):405-11. PubMed ID: 26098191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive assessment of cardiac structure and function in patients with treated malignant phase hypertension: the West Birmingham Malignant Hypertension project.
    Shantsila A; Dwivedi G; Shantsila E; Butt M; Beevers DG; Lip GY
    Int J Cardiol; 2013 Jul; 167(1):67-72. PubMed ID: 22192285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal.
    Zanchetti A; Thomopoulos C; Parati G
    Circ Res; 2015 Mar; 116(6):1058-73. PubMed ID: 25767290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacological management of malignant hypertension.
    Gosse P; Boulestreau R; Brockers C; Puel C; Rubin S; Cremer A
    J Hypertens; 2020 Nov; 38(11):2325-2330. PubMed ID: 32649635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of hypertensive crises: a clinical review.
    Pergolini MS
    Clin Ter; 2009; 160(2):151-7. PubMed ID: 19452106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant hypertension: a rare problem or is it underdiagnosed?
    Shantsila A; Shantsila E; Lip GY
    Curr Vasc Pharmacol; 2010 Nov; 8(6):775-9. PubMed ID: 20626341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular ventricular coupling in patients with malignant phase hypertension: the West Birmingham malignant hypertension project.
    Shantsila A; Dwivedi G; Shantsila E; Steeds RP; Beevers G; Lip GY
    Hypertens Res; 2012 Jul; 35(7):725-8. PubMed ID: 22357519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertensive crisis--an overview.
    Kumar A; Banerjee M
    J Indian Med Assoc; 1997 Sep; 95(9):511-2, 527. PubMed ID: 9529586
    [No Abstract]   [Full Text] [Related]  

  • 17. Mortality and cardiovascular risk in patients with a history of malignant hypertension: a case-control study.
    Amraoui F; Van Der Hoeven NV; Van Valkengoed IG; Vogt L; Van Den Born BJ
    J Clin Hypertens (Greenwich); 2014 Feb; 16(2):122-6. PubMed ID: 24373528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant Hypertension Revisited-Does This Still Exist?
    Shantsila A; Lip GYH
    Am J Hypertens; 2017 Jun; 30(6):543-549. PubMed ID: 28200072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement and treatment of elevated blood pressure in the pediatric patient with chronic kidney disease.
    Swinford RD; Portman RJ
    Adv Chronic Kidney Dis; 2004 Apr; 11(2):143-61. PubMed ID: 15216486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2014 Dec; 32(12):2285-95. PubMed ID: 25255397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.